共 50 条
- [1] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers[J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483Fukumura, KazuyaYokota, TakaakiBaba, YukoFerreira, Juan Camilo Arjona
- [2] Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (12)Liu, XiaoyanZhang, RuiLi, RongWu, QiongPan, ChaoYu, XiangqingLiu, YuhuiWang, BenjieYu, Shuwen
- [3] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study[J]. ADVANCES IN THERAPY, 2023, 40 (07) : 3186 - 3198Zhao, QianLiu, HongzhongWang, ZhenleiWang, TengCui, ChengWang, HuanhuanLi, LiliZhong, WenJiang, JiDong, KaiChen, ShuaiJin, ChunyanHu, Pei
- [4] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study[J]. Advances in Therapy, 2023, 40 : 3186 - 3198Qian ZhaoHongzhong LiuZhenlei WangTeng WangCheng CuiHuanhuan WangLili LiWen ZhongJi JiangKai DongShuai ChenChunyan JinPei Hu
- [5] Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (02) : 391 - 403Rocha, Jose-FranciscoSantos, AnaGama, HelenaMoser, PaulFalcao, AmilcarPressman, PeterWallace Hayes, A.Soares-da-Silva, Patricio
- [6] A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers[J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (06): : 661 - 669Jansen, MendelWarrington, StevenDishy, VictorOhwada, ShoichiJohnson, LisaBrown, KarenIshizuka, Hitoshi
- [7] Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial[J]. NUTRIENTS, 2023, 15 (10)Tan, Karen M. L.Chee, JoleneLim, Kezlyn L. M.Ng, MaisieGong, MinXu, JiaTin, FeliciaNatarajan, PadmapriyaLee, Bee LanOng, Choon NamTint, Mya ThwayKee, Michelle Z. L.Muller-Riemenschneider, FalkGluckman, Peter D.Meaney, Michael J.Kumar, MukkeshKarnani, NeerjaEriksson, Johan G.Nandanan, BinduWyss, AdrianCameron-Smith, David
- [8] Cardiovascular safety and pharmacokinetics of almotriptan:: a randomized, double-blind, placebo-controlled, crossover clinical trial in healthy volunteers[J]. CEPHALALGIA, 2003, 23 (07) : 706 - 706Salvà, MJansat, JMMartínez-Tobed, A
- [9] A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects[J]. DIABETES OBESITY & METABOLISM, 2024, 26 (08): : 3068 - 3077Xie, PanpanAbildlund, Morten T.Baekdal, Tine A.He, XuemeiLyauk, Yassine K.Patted, Usha Rani H.Ning, ZuShi, Aixin
- [10] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Multiple Oral Doses of CC 930 in Healthy Volunteers[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1343 - 1343Kong, LinghuiYe, YingLiu, LiangangReyes, JosephineWan, YuntaoWu, AnfanLau, HenryLaskin, Oscar